Larson Financial Group’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.1K Buy
669
+349
+109% +$7.83K ﹤0.01% 2168
2026
Q1
$7.22K Sell
320
-90
-22% -$2.07K ﹤0.01% 2420
2025
Q4
$9.77K Buy
410
+329
+406% +$8.18K ﹤0.01% 2127
2025
Q3
$2.13K Buy
81
+50
+161% +$1.28K ﹤0.01% 2684
2025
Q2
$886 Hold
31
﹤0.01% 2681
2025
Q1
$772 Hold
31
﹤0.01% 2457
2024
Q4
$702 Hold
31
﹤0.01% 2118
2024
Q3
$660 Hold
31
﹤0.01% 2070
2024
Q2
$592 Hold
31
﹤0.01% 1808
2024
Q1
$598 Hold
31
﹤0.01% 1528
2023
Q4
$646 Buy
+31
New +$595 ﹤0.01% 1542

Other funds holding FMS

Larson Financial Group's FMS Position: Q2 2026 in Review

Larson Financial Group increased its Fresenius Medical Care (FMS) stake by 109% in Q2 2026, buying an estimated $7.83K and bringing the position to 669 shares worth $15.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2168.

Larson Financial Group first reported a position in FMS in Q4 2023 and has held it in 11 quarters since. 233 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • Larson Financial Group held 669 shares of Fresenius Medical Care worth $15.1K as of Q2 2026.
  • Larson Financial Group bought 349 Fresenius Medical Care shares in Q2 2026, an estimated $7.83K.
  • Fresenius Medical Care made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2168 holding.
  • Larson Financial Group first reported a position in Fresenius Medical Care in Q4 2023 and has held it in 11 quarters since.
  • 233 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.